Imaging of Urothelial Cancers: What the Urologist Needs to Know

被引:11
作者
Lee, Eugene K. [1 ]
Dickstein, Rian J. [1 ]
Kamat, Ashish M. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Urol, Unit 1373, Houston, TX 77030 USA
关键词
bladder cancer; CT; diagnosis; MRI; staging; surveillance; ultrasound; urinary tract imaging; urothelial cell carcinoma; UPPER URINARY-TRACT; TRANSITIONAL-CELL-CARCINOMA; INVASIVE BLADDER-CANCER; RADICAL CYSTECTOMY; NEOADJUVANT CHEMOTHERAPY; MDCT UROGRAPHY; FOLLOW-UP; SURVIVAL; PATTERNS; TUMORS;
D O I
10.2214/AJR.10.6232
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. Imaging is vital in the diagnosis, staging, and surveillance of urothelial carcinomas. In this review, we discuss what treating urologists need to know from radiologists to optimally identify disease, plan surgery, determine prognosis, and identify patients in need of multimodal or alternative treatment strategies. We identify key points that a radiologist should convey to the treating urologist, in writing, in order to be an active partner in the formulation of an effective course of care. CONCLUSION. Because imaging plays a crucial role in the diagnosis, staging, and surveillance of patients with tumors of the urinary tract, it is imperative that radiologists provide information about the anatomic features related to the primary tumor, the surrounding anatomy, and involvement or lack of involvement of known potential landing sites for metastases. A good understanding of the imaging features that affect management of the disease and a good relationship between the radiologist and the urologist are vital to the care of patients with urothelial cancers.
引用
收藏
页码:1249 / 1254
页数:6
相关论文
共 30 条
  • [1] [Anonymous], 2008, Cancer Facts Figures 2008
  • [2] [Anonymous], NATL CANC I PUB
  • [3] [Anonymous], 2006, SEER cancer statistics review, 1975-2003
  • [4] [Anonymous], NCCN guidelines
  • [5] Transitional cell carcinoma of the upper urinary tract: Spectrum of imaging findings
    Browne, RFJ
    Meehan, CP
    Colville, J
    Power, R
    Torreggiani, WC
    [J]. RADIOGRAPHICS, 2005, 25 (06) : 1609 - 1627
  • [6] MDCT urography of upper tract urothelial neoplasms
    Caoili, EM
    Cohan, RH
    Inampudi, P
    Ellis, JH
    Shah, RB
    Faerber, GJ
    Montie, JE
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (06) : 1873 - 1881
  • [7] Preoperative hydronephrosis as an indicator of survival after radical cystectomy
    Chapman, Darren M.
    Pohar, Kamal S.
    Gong, Michael C.
    Bahnson, Robert R.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2009, 27 (05) : 491 - 495
  • [8] Do Patients Benefit from Routine Follow-up to Detect Recurrences After Radical Cystectomy and Ileal Orthotopic Bladder Substitution?
    Giannarini, Gianluca
    Kessler, Thomas M.
    Thoeny, Harriet C.
    Nguyen, Daniel P.
    Meissner, Claudia
    Studer, Urs E.
    [J]. EUROPEAN UROLOGY, 2010, 58 (04) : 486 - 494
  • [9] Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association Best Practice Policy - Part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up
    Grossfeld, GD
    Litwin, MS
    Wolf, JS
    Hricak, H
    Shuler, CL
    Agerter, DC
    Carroll, PR
    [J]. UROLOGY, 2001, 57 (04) : 604 - 610
  • [10] Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
    Grossman, HB
    Natale, RB
    Tangen, CM
    Speights, VO
    Vogelzang, NJ
    Trump, DL
    White, RWD
    Sarosdy, MF
    Wood, DP
    Raghavan, D
    Crawford, ED
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (09) : 859 - 866